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Abstract: The astonishing efficiency with which living organisms build complex molecules from 
abundant starting materials has inspired chemists for centuries. Among the synthetic strategies that 
nature uses to achieve this efficiency, the combination of several enzymatic transformations in 
cascading sequences is of outstanding importance. With the rise of biocatalysis, researchers now 
have the tools at hand to mimic this strategy and develop artificial enzyme cascades of impressive 
complexity. This editorial review aims to introduce the reader to some key aspects of 
(Chemo)enzymatic Cascades, as well as to put the submissions to the present Special Issue into a 
broader perspective. 
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Highlights: 
 Cascade sequences of biotransformations are a key aspect of nature’s synthetic strategy. 
 Multi-enzymatic and chemo-enzymatic cascades attract increasing interest in biocatalysis. 
 The term ‘cascade’ is used in a very broad sense for a variety of biocatalytic one-pot systems, 
which can, however, be classified into a limited number of general designs. 
 The contributions to this Special Issue cover many aspects of the topic, and illustrate many of the 
advantages of (Chemo)enzymatic Cascades. 
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1 Introduction: Nature’s synthetic strategy 
The most efficient chemical factories known are the living organisms. Their exquisite efficiency is due 
to the synthetic strategy — in the sense that Nicolaou gave to this expression[1] — that evolution has 
optimised over time. This natural synthetic strategy is based on three key aspects: (i) the use of 
enzymes as catalysts; (ii) compartmentalisation of enzymes or even entire biosynthesis routes in 
cellular organelles or compartments; and (iii) the sequential use of these catalysts in cascade 
reactions (biosynthetic pathways). Biocatalysis, to reach its objective of transferring the exquisite 
synthetic efficacy that enzymes show in nature to the laboratory, had to mimic this approach. 
Much has already been said about the advantages offered by enzymes as catalysts and about the role 
of recombinant DNA techniques, especially PCR, in facilitating the production of many enzymes that 
were previously difficult to access, and that are capable of catalysing a myriad of chemical 
reactions.[2-4] In addition, these techniques have allowed the development of strategies to engineer 
aspects of enzymatic catalysis that are of main importance, such as substrate specificity, regio- and 
enantioselectivity, stability, etc.[4-9] Compartmentalisation into different organelles as observed in 
living beings is mimicked in the field of biocatalysis by different immobilisation strategies (physical 
confinement of an enzyme or several enzymes in a given region of space), such as 
microencapsulation, or entrapment in liposomes or hollow fibers, among other examples.[10-11] 
The third cornerstone of the natural synthetic strategy is the use of enzymes acting sequentially in 
(sometimes very complicated) biosynthetic routes. This joint, cascading action of a sequence of 
enzymes allows living organisms to build complex structures from simple starting materials, to obtain 
and to store energy, and to explore and to communicate with their environment. During the course 
of evolution, complex metabolic networks to perform thousands of different chemical reactions that 
take place inside a cell have been developed. In these processes the product of one enzyme is the 
substrate for the next one, allowing rapid complexity generation, the shifting of reaction equilibria, 
the elimination of inhibition problems caused by product excess, or the channelling of substrates 
from one active site to another. In the field of biocatalysis, multi-enzyme cascades may be 
implemented via the use of isolated multi-enzyme systems in homogeneous phase to create artificial 
pathways (also called artificial metabolisms),[12] which offer essentially the same advantages. In 
nature, some multi-enzymatic routes have been optimised throughout evolution by joining two or 
more enzymes in a single protein, giving rise to the appearance of multifunctional enzymes or 
enzyme complexes. This approach can also be mimicked by biocatalysis, for instance by crosslinking 
several proteins using bifunctional reagents, by fusion of genes encoding different enzymes or by 
modular assembling of proteins on synthetic scaffolds.[13-17] 
Over the course of the last decade, biocatalytic cascade reactions have grown into an intensively 
investigated research area, as evidenced by more than 100 articles published on this topic in the last 
five years,[18-23] and by the organisation of a series of international conferences dedicated to this 
subject. The Multistep Enzyme-Catalyzed Processes (MECP) conference series was organised under 
the auspices of the European Section on Applied Biocatalysis (ESAB) and promoted, among others, by 
Professor Herfried Griengl, who chaired the first MECP conference held in Graz in April 2006. It was 
necessary to wait six years, until April 2012, to celebrate the second MECP conference, which was 
also held in Graz, co-organized by the University of Graz, the Graz University of Technology, and the 
Austrian Centre of Industrial Biotechnology (ACIB). However, due to rapid growth in this field it was 
only two years later that the most recent edition of the series, MECP14, was held in Madrid, co-
organized by the Spanish National Research Council (CSIC) and the Spanish Society of Biotechnology 
(SEBiot). 
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It was during the organisation phase of MECP14 when the idea to edit this special issue of the Journal 
of Molecular Catalysis B: Enzymatic devoted to (Chemo)Enzymatic Cascade Reactions emerged and 
crystallised and therefore the Guest Editors are indebted to this conference. 
2 Biocatalytic cascades: definitions and classifications 
The rapid growth of biocatalytic cascade reactions as a research topic has led to the development of 
a broad variety of cascade systems that adopt different key aspects of nature’s synthetic strategy. 
The majority of the reported reaction systems comprise several enzymes working together 
concurrently in the same reaction vessel. However, multi-enzyme systems to which the involved 
biocatalysts are added sequentially at different time points, and sequences of spontaneous reactions 
that are merely initiated by an enzymatic transformation are commonly referred to as cascades as 
well. Indeed, recent literature examples of biocatalytic cascades (as categorised by the authors) 
range from complex multi-enzyme networks that combine ten or more individual 
biotransformations,[24-25] to simple transamination reactions that are rendered irreversible via the 
spontaneous aromatisation of the reaction co-product (Scheme 1).[26] 
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Scheme 1. Two literature examples illustrating the diverse use of the term ‘biocatalytic cascade’: (A) Conversion of D-
glucose into isobutanol by an eight-enzyme, ten-step reaction sequence; (B) conversion of acetophenone into (S)-1-
phenylethylamine using an amino donor that shifts the reaction equilibrium by spontaneous aromatisation. Both systems 
have been described as ‘biocatalytic cascade’ by the authors in their respective publications. Enzyme acronyms: GDH, 
glucose dehydrogenase; DHAD, dihydroxy acid dehydratase; KDGA, 2-keto-3-deoxygluconate aldolase; AlDH, 
glyceraldehyde dehydrogenase; ALS, acetolactate synthase; KARI, ketol-acid reductoisomerase; KDC, 2-ketoacid 
decarboxylase; ADH, alcohol dehydrogenase; ω-TA, ω-transaminase. 
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This tendency towards terminological generalisation has a simple reason: There is just no commonly 
accepted definition of the term ‘cascade reaction’, or of related descriptors such as ‘domino’ or 
‘tandem’ – neither in the context of the chemical sciences in general, nor within the particular field 
of biocatalysis. Still, some authors have tried to bring order to this area of reaction terminology by 
proposing clearly distinct meanings for the three above-mentioned terms. For instance, in a review 
article published in 2001, Faber and coworkers distinguish between biocatalytic ‘domino’ (or 
‘cascade’) systems as spontaneous sequences that proceed via highly reactive intermediates and are 
only initiated by an enzyme, and ‘tandem’ systems, which combine several enzymatic 
transformations that in principle could also be carried out separately.[27] This is a sensible 
differentiation, especially in view of the classical definition of domino reactions put forth by 
Tietze,[28] and of the now widely accepted term ‘tandem catalysis’ for one-pot combinations of 
several catalysts.[29-30] However, many authors still use the three terms rather interchangeably, 
and particularly within the biocatalysis research community, ‘cascade’ seems to have become the 
descriptor of choice for almost any type of one-pot process. 
For the purpose of this Special Issue, we have chosen to follow the trend apparent in the recent 
literature and adopt a fairly broad conception of (chemo)enzymatic cascades – one that includes all 
concurrent biocatalytic one-pot systems, irrespective of whether they combine several enzymes, 
enzymes and chemocatalysts, or enzymes and spontaneous (non-catalysed) transformations. We 
believe that such a broad use of the term is warranted not only by the according example of other 
researchers in the field, but also by the general characteristics that these systems have in common. 
All one-pot systems, irrespective of whether the involved reactions take place concurrently or in 
temporally separated fashion, share the obvious advantages arising from the elimination of 
intermediate work-up and purification steps: operational simplicity combined with a reduced 
consumption of chemicals (particularly solvents), energy, space, and time.[31] Cascades as 
concurrent one-pot sequences offer additional benefits that result from the immediate succession of 
the individual transformations. For instance, toxic or unstable intermediates may be consumed in the 
same instant as they appear, which leads to safer processes and prevents undesired side reactions. 
Likewise, reversible reactions may be driven to completion by a thermodynamically favourable 
follow-up reaction. 
Creative cascade design is crucial for capitalising on these potential benefits, and biocatalysis offers 
ample possibilities in this regard: In nature, enzymes operate under a rather narrow range of 
conditions (compared to man-made catalysts), which often results in overlapping reaction optima 
and hence high compatibility. Moreover, many enzymatic transformations depend on the presence 
of a cofactor – a circumstance that is traditionally seen as a challenge for application, but may also 
represent an additional opportunity for coupling several reactions in a cascade system.[32] 
Consequently, biocatalytic reactions have been combined in many different ways, and for many 
different purposes. Nonetheless, most published cascade systems can be assigned to one out of four 
designs with their distinct characteristics and advantages.[21] 
The most straightforward design is a linear sequence of transformations, which convert a single 
substrate into a single product via one or more intermediates (Scheme 2, A). Enzyme-initiated 
spontaneous domino reactions fall into this category, as do many multi-enzymatic and chemo-
enzymatic reaction systems. Indeed, even dynamic kinetic resolution (DKR) processes can be viewed 
as a special type of linear cascade, in which the (reversible) interconversion of substrate enantiomers 
is coupled to the (irreversible) transformation of preferably only one enantiomer into a product that 
is stereochemically stable under the reaction conditions. The displacement of unfavourable equilibria 
and the in situ generation of toxic or unstable intermediates are common benefits of linear designs. 
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Scheme 2. General cascade designs: (A) Linear cascade, (B) orthogonal cascade, (C) parallel cascade, and (D) cyclic cascade. 
Orthogonal designs, in contrast, comprise only a single synthetically relevant transformation, which is 
coupled to ‘auxiliary’ reactions that promote the formation of the desired product; for instance, by 
the regeneration of cofactors or cosubstrates, or by the removal of troublesome coproducts (Scheme 
2, B). Whether straightforward cofactor regeneration systems do already constitute biocatalytic 
cascades may be questionable, but there are literature examples of auxiliary reaction setups that do 
undoubtedly deserve to be termed orthogonal cascades. A classic case is Soda’s system for the 
production of D-amino acids from α-keto acids catalysed by a D-amino acid transaminase in 
combination with glutamate racemase, L-glutamate dehydrogenase and formate dehydrogenase for 
regeneration of the cosubstrate D-glutamate (Scheme 3).[33] 
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Scheme 3. A classic example of an orthogonal cascade design: A D-amino acid transaminase is combined with three 
auxiliary enzymes to realise a formal D-selective reductive amination of keto acids using ammonium formate as sole 
stoichiometric reagent. Enzyme acronyms: D-AAT, D-amino acid transaminase; GluR, glutamate racemase; GluDH, L-
glutamate dehydrogenase; FDH, formate dehydrogenase. 
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In parallel cascade designs, the problem of cofactor regeneration is addressed in a different way: 
Instead of coupling the desired transformation to a synthetically irrelevant auxiliary reaction, it is 
combined with a second reaction of synthetic interest and matching cofactor demand (Scheme 2, C). 
For instance, the kinetic resolution of a chiral alcohol catalysed by an alcohol dehydrogenase (ADH) 
may be coupled to the asymmetric reduction of a prochiral ketone by the same enzyme, resulting in 
a closed redox cycle.[34] While parallel designs ensure efficient use of the involved cofactors or 
cosubstrates, they suffer from the disadvantage of affording several products, which require 
separation. The benefits of the simple reaction setup might hence be outweighed by issues of 
downstream processing.  
Cyclic cascade designs are also possible, but are limited to special applications. The most common 
examples are deracemisation systems for amines, α-amino acids, sec-alcohols, or α-hydroxy acids 
that combine enantioselective oxidation with non-stereoselective reduction. In these systems, one 
enantiomer of the racemic substrate is selectively oxidised to a prochiral analogue (an imine, α-imino 
acid, ketone, or α-keto acid, respectively), which in turn is reduced back to the racemic starting 
material (Scheme 2, D). Over several cycles of this redox cascade, the more slowly oxidised 
enantiomer accumulates. Until recently, cyclic cascades of this type have been limited to chemo-
enzymatic systems, usually combining an oxidase with ammonia-borane as reducing agent. Only in 
2013, Ward, Turner, Hollmann, and co-workers have demonstrated that the combination of a 
monoamine oxidase and an artificial transfer hydrogenase (i.e., a biotinylated iridium complex bound 
to streptavidin) can effect the same transformations with high efficiency and minimal interference of 
the catalysts.[35] 
Overall, the four main types of cascade designs provide only a loose framework for the classification 
of enzymatic cascade processes. Combinations of these approaches are possible and may further 
increase the efficiency of a multi-enzyme system. For instance, the main ideas of linear and parallel 
designs (implementation of a one-pot sequence of reactions, and internal recycling of cofactors, 
respectively) can be combined in redox-neutral linear cascades, where the first transformation 
provides the cofactor for the second, and vice versa.[36] Likewise, a cyclic element can be introduced 
into a linear sequence if a coproduct of the second step is at the same time a substrate for the first 
(an approach called ‘regeneration cascade’ by Rother and co-workers).[37] Moreover, any type of 
biocatalytic cascade can be practically implemented in a variety of ways: the involved enzymes may 
be simply combined in solution, they may be coexpressed in the same microbial cell (or expressed 
separately in different hosts, which are later combined), they may be co-localised via immobilisation 
or encapsulation, or kept at distance from each other via compartmentalisation, depending on what 
suits the investigated reaction system best. The possibilities for the creative design of biocatalytic 
cascades are therefore virtually limitless, and we hope that the examples collected in this Special 
Issue will help to illustrate the broad scope of options. 
3 Examples of cascades in this Special Issue 
In the present issue we have tried to cover some areas related to (chemo)enzymatic cascade 
protocols through two review and ten article contributions made by leading authors in the field. 
Thus, due to the relevance of enantiomerically pure 2-hydroxycarboxylic acid derivatives, van 
Rantwijk & Stolz [38] summarise the recent development of enzymatic cascades to obtain these 
compounds by combination of hydroxynitrile lyases together with nonselective nitrile hydratases or 
nitrilases to obtain the corresponding 2-hydroxyamides and 2-hydroxycarboxylic acids, respectively. 
The authors focus especially on the effects of different enzyme preparations (e.g., using whole cell 
systems or cross-linked enzyme aggregates), and on the use of directed mutagenesis of the nitrilase, 
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providing a selective biocatalyst applied to these processes. Sehl, Maugeri & Rother [39] cover 
recent examples of asymmetric multi-step synthetic routes to obtain vicinal amino alcohols, 
molecules with wide applications in chemical industry as precursors of various drugs. They highlight 
some recently developed chemoenzymatic protocols especially focusing on phenylpropanolamines 
such as norpseudoephedrine and norephedrine. Among the different enzymatic strategies 
developed, the combination of transaminases with carboligases or alcohol dehydrogenases has 
gained more relevance in the last years to synthesise these compounds. 
As already mentioned above, one of the most prominent advantages related to the implementation 
of multi-step one-pot transformations is their step economy. Carrying out several reactions in direct 
succession without purification of intermediates helps to maximise the overall yield and minimise the 
use of reagents, catalysts and solvents. Various contributions to this issue demonstrate this point: 
Romano et al. [40] have designed a new chemoenzymatic synthesis of precursors to Bimatoprost and 
Latanoprost, two prostaglandin analogues employed for glaucoma treatment, by using Pichia 
anomala yeast containing three reacting enzymes (an esterase, an alcohol dehydrogenase and an 
enoate reductase). Thus, these biocatalysts are responsible of an ester hydrolysis, a stereoselective 
ketone reduction and a carbon-carbon double bond reduction, respectively. Moreover, by modifying 
the reaction medium it is possible to suppress the C=C reduction activity, giving access to an 
unsaturated building block. Kurina-Sanz et al. [41] have shown a one-pot two-step protocol to get 
access to several epoxides and diols starting from the corresponding α-chloro or α-
bromoacetophenone derivatives. After stereoselective bioreduction employing resting or lyophilised 
Rhodotorula sp. LSL yeast cells in plain water without the addition of an external cofactor or a 
hydrogen donor, the cyclisation of the corresponding enantioenriched (R)-halohydrins is achieved 
under alkaline conditions. Brenna et al. [42] have demonstrated the application of two isolated 
enzymes, an enoate reductase from Saccharomyces cerevisiae and an alcohol dehydrogenase from 
Rhodococcus erythropolis or from Parvibaculum lavamentivorans, to obtain the most odorous 
stereoisomers of the commercial fragrance Muguesia®. Thus, starting from a prochiral α,β-
unsaturated ketone precursor, both diastereomers are attained in high yields and selectivities. In a 
similar scheme, Gatti et al. [43] show the application of an enoate reductase from Saccharomyces 
cerevisiae and an alcohol dehydrogenase from Rhodococcus erythropolis or from a commercial 
source, in order to give access to the four possible stereoisomers of a β-substituted γ-hydroxy ester 
precursor of Nicotiana tabacum lactone, a compound with great potential in the fragrance field. 
After biotransformation using both enzymes, a final cyclisation step in acidic conditions is performed 
to access all diastereomers in high yields and excellent enantio- and diastereoselectivities. 
Multi-step protocols can also be useful for in situ generation of chemical species that are unstable or 
that can be harmful to the (bio)catalyst, thus being continuously provided at low concentrations to 
immediately react within a second substrate. Gotor, Gotor-Fernández and co-workers [44] describe 
a one-pot chemoenzymatic methodology to synthesise a series of γ-butyrolactone derivatives from 
the corresponding 3-substituted cyclobutanones via Baeyer–Villiger oxidation. Peracetic acid, which 
acts as the oxidising species, is formed in situ by lipase-catalysed perhydrolysis of ethyl acetate in the 
presence of the urea–hydrogen peroxide complex, thereby minimising its poisoning effect on the 
biocatalyst. After reaction optimisation, lipase B from Candida antarctica was selected as the best 
candidate, and the target lactones were isolated in high yields after a simple extraction protocol. 
Using a similar approach, Wiemann et al. [45] demonstrate the epoxidation of limonene in good 
yield through perhydrolysis of ethyl acetate catalysed by lipase B from Candida antarctica. In this 
case the formation of hydrogen peroxide is attained by a two-step cascade process: reduction of 
anthraquinone into anthrahydroquinone using hydrogen and a palladium catalyst, followed by auto-
oxidation yielding equimolar amounts of H2O2. 
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Another advantage derived from cascade methods can be the generation in the reaction medium of 
chemical species that are expensive and that can be (enzymatically) obtained from a cheaper source. 
Lemaire et al. [46] describe different one-pot multi-step stereoselective cascade reactions applied to 
the straightforward synthesis of various nitrocyclitols. In these systems, two kinases (acetate kinase 
and dihydroxyacetone kinase) are used to obtain dihydroxyacetone phosphate from 
dihydroxyacetone, which subsequently reacts with a nitroaldehyde in the presence of an aldolase (L-
fuculose-1-phosphate aldolase or L-rhamnulose-1-phosphate aldolase), responsible for the selective 
C–C bond formation. Then, a spontaneous intramolecular Henry reaction provides the nitrocyclitol 
moiety with high diastereoselectivity. Finally, a phosphatase (acid phosphatase from wheat germ) is 
employed to dephosphorylate the final compounds. The stereoselectivities displayed by the 
aldolases vary depending on the aldehyde used, and the configuration of the aldol adduct has a 
profound influence on the stereochemical outcome of the Henry reaction. Lewkowicz et al. [47] 
propose several multi-step enzymatic systems to synthesise pyrimidine nucleoside 5’-diphosphates 
starting from readily accessible reagents. To access uridine 5’-diphosphate, a simple methodology is 
used involving commercial yeast extract as biocatalyst and uridine 5’-monophosphate, prepared 
employing whole cells from Corynebacterium ammoniagenes in the presence of uracil and orotic 
acid, or Raoultella planticola from uridine. For thymidine 5’-diphosphate synthesis, two one-pot 
multi-step systems are used sequentially. 2’-Deoxyribose-5-phosphate is formed from glucose by 
Erwinia carotovora whole cells, followed by the action of phosphopentomutase and thymidine 
phosphorylase, affording thymidine in high yield. Then, this nucleoside is converted into the final 
product combining E. coli BL21 pET22b-phoRp (a strain expressing an acid phosphatase from R. 
planticola) and S. cerevisiae. 
Dynamic protocols are widely employed in recent years as an efficient way to obtain 
enantiomerically pure products at high extent from easily available racemates. In these concurrent 
processes, the combination of several catalysts can improve the yield of the desired compound by 
recycling the non-reacting enantiomer via racemisation. Ansorge-Schumacher, Kara and co-workers 
[48] have studied the dynamic kinetic resolution of benzoin combining a lipase from Pseudomonas 
stutzeri with a heterogenous chemocatalyst (Zr-TUD-1) used as the racemising agent. Especial 
attention is set on the effect of water activity and the reaction solvent employed. Hence, different 
co-solvents are studied, including deep eutectic solvents. After optimisation, cyclopentyl methyl 
ether is selected as the best candidate, and the process is run in a continuous fashion in a stirred 
tank reactor to synthesise the (S)-benzoin ester in enantiopure form. 
In the last years, multi-step systems are also being used as sensitive assays for determining a specific 
target. Charmantray et al. [49] have developed a fluorometric assay for the determination of 
dihydroxyacetone phosphate (DHAP). This compound is reduced to L-glycerol-3-phosphate with α-
glycerophosphate dehydrogenase, and is recycled via the oxidation reaction catalysed by α-
glycerophosphate oxidase, releasing hydrogen peroxide. Then, the reaction of H2O2 with Amplex® 
Red reagent in the presence of horseradish peroxidase leads to the fluorescent product resorufin. 
The limit of quantification of DHAP has been estimated at 1 pmol (5 nM), roughly 2250-fold more 
sensitive than the usual assay based on spectrophotometric detection. 
4 Conclusions 
Inspired by nature’s biosynthetic pathways, scientists have developed a vast variety of reaction 
systems in which enzymatic transformations are coupled to each other, or to chemo-catalytic or even 
spontaneous reactions. As diverse as these systems can be, they are usually all subsumed under the 
term “cascade”, which therefore has acquired a very generic meaning. In the present Special Issue of 
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the Journal of Molecular Catalysis B: Enzymatic we have tried to cover the topic in all its breadth: 
from the simple biocatalytic formation of a reactive species to complex multi-enzyme systems, from 
continuously operated preparative transformations to a fast and highly sensitive small-scale assay. 
The examples collected in this issue show the enormous potential offered by (chemo)enzymatic 
cascade reactions, demonstrating many advantages over conventional sequential reaction schemes 
in terms of productivity, selectivity, and cost as well as environmental efficiency. We are convinced 
that the ongoing efforts in this research area will bring us closer to achieving the goal of transferring 
nature’s synthetic efficiency to the laboratory. 
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